Trial intelligence / Profile preview

S-ketamine effects on brain monitoring and sedation levels

RBR-5cqxrrxPhase 4Completed

Sponsor
Hospital São Carlos
Start
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of esketamine (3 arms), sponsored by Hospital São Carlos. Started Aug 2022; status: completed.

02

Drugs

esketamine

Beyond the preview

Go deeper on RBR-5cqxrrx.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-5cqxrrx.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call